documents: FDA-2013-D-1444-0037
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2013-D-1444-0037 | FDA | FDA-2013-D-1444 | Final Guidance; Pharmacy Compounding of Human Drug Products Under Section 503A of the Federal Food, Drug, and Cosmetic Act; Availability | Notice | Notice of Availability | 2014-07-02T04:00:00Z | 2014 | 7 | 2014-07-02T04:00:00Z | 2014-07-03T13:06:52Z | 2014-15372 | 0 | 0 | 09000064817870fb |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref